Larson-Green Julie
SEC Form 4 insider trading activity
Larson-Green Julie has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Larson-Green Julie is listed as Director at Health Catalyst, Inc. Inside the rolling window, Larson-Green Julie reported no open-market purchases and 1 open-market sale totaling $128K in HCAT.
Companies traded
Other insiders at HCAT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$128K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Larson-Green Julie made?
Larson-Green Julie has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Larson-Green Julie trade?
Larson-Green Julie has filed SEC Form 4 disclosures for 1 company, including HCAT.
When was Larson-Green Julie's most recent SEC Form 4 filing?
Larson-Green Julie's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Larson-Green Julie's total buy and sell value in the current window?
Inside the rolling retention window, Larson-Green Julie bought $0 and sold $128K based on SEC Form 4 filings.
What was Larson-Green Julie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 47,997 HCAT shares on 2025-12-04, worth $128K, per SEC Form 4 filings.